- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low-dose nivolumab in advanced hepatocellular carcinoma ; volume:22 ; number:1 ; day:8 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
BMC cancer ; 22, Heft 1 (8.11.2022), 1-12, 12.2022
- Creator
-
Chen, Yen-Hao
Wang, Chih-Chi
Chen, Yen-Yang
Wang, Jing-Houng
Hung, Chao-Hung
Kuo, Yuan-Hung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-10271-6
- URN
-
urn:nbn:de:101:1-2023012209543418831886
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Yen-Hao
- Wang, Chih-Chi
- Chen, Yen-Yang
- Wang, Jing-Houng
- Hung, Chao-Hung
- Kuo, Yuan-Hung
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
Low-dose quercetin positively regulates mouse healthspan
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
Low-dose quercetin positively regulates mouse healthspan
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
ASO Author Reflections: Neoadjuvant Radiotherapy in Locally Advanced Esophageal Adenocarcinoma; Low-Dose Radiation, Low-Dose Expectations?
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports
Low-dose lithium against dementia
Low-dose oral methotrexate-induced crystalluria
Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma
Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma